Lipedema awareness in fibromyalgia
| dc.contributor.author | Bolkan Günaydın E. | |
| dc.contributor.author | Ünlü Z. | |
| dc.contributor.author | Ay S. | |
| dc.contributor.author | Karapınar T.O. | |
| dc.date.accessioned | 2025-04-10T11:01:46Z | |
| dc.date.available | 2025-04-10T11:01:46Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Objectives: To evaluate the presence of lipedema and lipedema-related factors in fibromyalgia patients. Methods: The study included 100 female patients over the age of 18 who met the fibromyalgia diagnostic criteria. The patients were evaluated for the presence/stages of lipedema. The body mass index (BMI), waist-hip ratio, waist-height ratio, and presence of hematoma tendency/telangiectasias were recorded. Patients were asked to mark the severity of their pain (widespread/on lipedema) on a 10 cm visual analog scale (VAS). The ACR 2016 Fibromyalgia Diagnostic Criteria, The Beck Depression Inventory (BDI), and The Revised Fibromyalgia Impact Questionnaire were applied. Results: Lipedema was observed in 50% of the patients (58% Stage 1 lipedema). In the lipedema group, age, duration of fibromyalgia diagnosis, hematoma tendency/presence of telangiectasias (for all; p <.001), menopausal status (p =.004), BDI score (p =.04), BMI (p =.02), history of medication for fibromyalgia (p =.01) were higher, and age at menarche (p =.01) was lower. Lipedema stage was moderately positively correlated with BMI, number of pregnancies (for both; r:0.53 p <.001) and waist-height ratio (r:0.43 p:0.002), while VAS-lipedema pain intensity was strongly positively correlated with VAS-widespread pain intensity (r:0.62 p <.001), and moderately positively correlated with symptom severity score (r:0.55 p <.001), BMI (r:0.54 p <.001), and fibromyalgia severity score (r:0.51 p <.001). Long fibromyalgia diagnosis time (p: 0.005), and low age at menarche (p: 0.05) were significant risk factors for the presence of lipedema. Conclusions: Lipedema is common in fibromyalgia patients. Long fibromyalgia diagnosis time and low age at menarche are significant risk factors for the presence of lipedema. © The Author(s) 2025. | |
| dc.identifier.DOI-ID | 10.1177/02683555251321042 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/43629 | |
| dc.publisher | SAGE Publications Ltd | |
| dc.title | Lipedema awareness in fibromyalgia | |
| dc.type | Article |